First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 12.6% of the 39,711 shares held after it.
1 other insider bought within 30 days.
19 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Rosenjack Richard C bought about $16.9K of CVU on Nov 19, 2024; 1 other insider bought within 30 days and 19 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 28.0% of the 35,777 shares held after it.
1 other insider bought within 30 days.
19 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Levesque Pamela bought about $31.3K of CVU on Nov 18, 2024, the largest insider purchase at the company since 2022; 1 other insider bought within 30 days and 19 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (5 buys), the last on Aug 22, 2024.
+30.7% median (+31.4% mean) 90-day return after 3 previous buys.
The trade is 7.5% of the 132,981 shares held after it.
1 other insider bought within 30 days.
19 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Caswell Richard S bought about $28.8K of CVU on Aug 26, 2024, the largest insider purchase at the company since 2022; 1 other insider bought within 30 days and 19 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 5.7% of the 175,887 shares held after it.
1 other insider bought within 30 days.
19 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Carey Bond E bought about $27.0K of CVU on Aug 22, 2024, the largest insider purchase at the company since 2022; 1 other insider bought within 30 days and 19 funds added in the latest 13F quarter.
15 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CVU planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
CVU mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Royce Capital Fund - Micro-Cap Portfolio
$519.7K position · as of 2026-06-30
0.4%
Royce Micro-Cap Fund
$1.6M position · as of 2026-06-30
0.4%
Ultra-Small Company Market Fund
$110.0K position · as of 2026-06-30
0.1%
Gabelli Global Mini Mites Fund
$5.2K position · as of 2026-06-30
0.0%
iShares Micro-Cap ETF
$175.3K position · as of 2026-06-30
0.0%
1290 VT Micro Cap Portfolio
$11.5K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Dorith Hakim
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$838.6K
$608.6K
$345.9K
+48%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 19 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$73.6M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CVU
FY Dec 2025
$69.3M
FY Dec 2024
$81.1M
FY Dec 2023
$86.5M
FY Dec 2022
$83.3M
FY Dec 2021
$103.4M
Jun 2026
$17.6M
Mar 2026
$17.4M
Dec 2025
$19.4M
Sep 2025
$19.3M
Jun 2025
$15.2M
Mar 2025
$15.4M
Dec 2024
$21.8M
Sep 2024
$19.4M
At each fiscal year end
Single quarter
Net margin, TTM
+5.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CVU
FY Dec 2025
-1.2%
FY Dec 2024
+4.1%
FY Dec 2023
+19.9%
FY Dec 2022
+11.0%
FY Dec 2021
+6.6%
Jun 2026
+3.9%
Mar 2026
+7.1%
Dec 2025
+3.6%
Sep 2025
+5.8%
Jun 2025
-8.7%
Mar 2025
-8.6%
Dec 2024
+4.5%
Sep 2024
+3.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$2.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CVU
FY Dec 2025
-$5.3M
FY Dec 2024
$3.2M
FY Dec 2023
$3.8M
FY Dec 2022
$903.5K
FY Dec 2021
n/a
Jun 2026
-$8.5K
Mar 2026
-$477.8K
Dec 2025
-$2.1M
Sep 2025
$211.1K
Jun 2025
-$599.8K
Mar 2025
-$2.8M
Dec 2024
$4.3M
Sep 2024
$586.9K
At each fiscal year end
Single quarter
Debt to equity
0.43x
long-term 2026-03-31 plus current 2022-09-30 (45 months older than the period end); equity 2026-06-30
Debt to equity CVU
FY Dec 2025
0.39x
FY Dec 2024
0.10x
FY Dec 2023
0.00x
FY Dec 2022
0.43x
FY Dec 2021
n/a
Jun 2026
0.43x
Mar 2026
0.45x
Dec 2025
0.39x
Sep 2025
0.10x
Jun 2025
0.11x
Mar 2025
0.11x
Dec 2024
0.10x
Sep 2024
0.10x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.19x
TTM operating cash flow over long-term 2026-03-31 plus current 2022-09-30 (45 months older than the period end)
Cash flow to debt CVU
FY Dec 2025
-0.52x
FY Dec 2024
1.36x
FY Dec 2023
55.34x
FY Dec 2022
0.53x
FY Dec 2021
0.57x
Jun 2026
-0.19x
Mar 2026
-0.24x
Dec 2025
-0.52x
Sep 2025
0.49x
Jun 2025
0.68x
Mar 2025
0.69x
Dec 2024
1.36x
Sep 2024
0.87x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+14.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CVU
FY Dec 2025
-3.3%
FY Dec 2024
+13.7%
FY Dec 2023
+130.9%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+14.4%
Mar 2026
+6.6%
Dec 2025
-3.3%
Sep 2025
-2.3%
Jun 2025
-3.9%
Mar 2025
+7.6%
Dec 2024
+13.7%
Sep 2024
+106.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CVU
FY Dec 2025
-1.2%
FY Dec 2024
+4.6%
FY Dec 2023
+25.7%
FY Dec 2022
+16.0%
FY Dec 2021
+13.4%
Jun 2026
+4.9%
Mar 2026
+2.4%
Dec 2025
-1.2%
Sep 2025
-0.8%
Jun 2025
-1.3%
Mar 2025
+2.7%
Dec 2024
+4.6%
Sep 2024
+26.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+12.7%
operating income after a 19.9% effective tax rate, over long-term 2026-03-31 plus current 2022-09-30 (45 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital CVU
FY Dec 2025
n/a
FY Dec 2024
+18.8%
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+12.7%
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
+12.6%
Dec 2024
+18.8%
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+12.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CVU
FY Dec 2025
-0.4%
FY Dec 2024
+16.0%
FY Dec 2023
+17.5%
FY Dec 2022
+18.5%
FY Dec 2021
+15.7%
Jun 2026
+12.0%
Mar 2026
+6.1%
Dec 2025
-0.4%
Sep 2025
+1.5%
Jun 2025
+0.8%
Mar 2025
+11.6%
Dec 2024
+16.0%
Sep 2024
+17.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
17.04x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CVU
FY Dec 2025
n/a
FY Dec 2024
15.58x
FY Dec 2023
1.98x
FY Dec 2022
4.32x
FY Dec 2021
4.96x
Jun 2026
18.54x
Mar 2026
30.15x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
23.13x
Dec 2024
15.58x
Sep 2024
2.51x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value CVU
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-3.8%
TTM free cash flow over market value at close 2026-10-26
FCF yield CVU
FY Dec 2025
-10.1%
FY Dec 2024
+6.0%
FY Dec 2023
+10.9%
FY Dec 2022
+2.3%
FY Dec 2021
n/a
Jun 2026
-3.5%
Mar 2026
-5.7%
Dec 2025
-10.1%
Sep 2025
+3.5%
Jun 2025
+3.4%
Mar 2025
+3.1%
Dec 2024
+6.0%
Sep 2024
+4.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing CVU
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
0.02x
FY Dec 2022
0.13x
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
0.03x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CVU ranks highest on profitability (71st percentile) and risk and compliance (66th), and lowest on institutional and government (6th), among Aerospace & Defense peers.
Profitability
71
Inputs
Return on equity+14.4% · 82 pct, sector of 41
Return on assets+4.9% · 70 pct, sector of 48
Return on invested capital+12.7% · 53 pct, universe of 1,069
Return on capital employed+12.0% · 79 pct, sector of 40
Financial health
42
Inputs
Debt to equity0.43x · 39 pct, sector of 42
Cash flow to debt-0.19x · 46 pct, sector of 38
Growth
40
Inputs
Revenue growth, YoY-14.6% · 14 pct, sector of 51
Backlog growth, YoY+15.2% · 66 pct, universe of 854
Institutional and government
6
Inputs
Funds adding, latest quarter19 · 6 pct, sector of 53
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
66
Inputs
Short interest, % of float+0.5% · 92 pct, sector of 61
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 38
New text in Risk Factors, latest 10-K+54.2% · 6 pct, sector of 36
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.